MedTrace Logo

Feasibility and Safety of Robotic Bariatric Surgery Using the SenhanceTM Surgical System

NCT05208138 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2022-11-04

No results posted yet for this study

Summary

Evaluating feasibility and safety of the Senhance Surgical System with digital laparoscopy in bariatric surgery.

Conditions

  • Bariatric Surgery Candidate

Interventions

DEVICE

Senhance Surgical System from Asensus

Bariatric operation with the Senhance Surgical System

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Philipp C Nett, MD · Inselspital Universitätsspital Bern

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-20
Primary Completion
2022-06-15
Completion
2022-06-15

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05208138 on ClinicalTrials.gov